Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 15, 2026
Rocket Lab (RKLB): +80% Surge in 30 Days on Record Revenue and Backlog Growth

Rocket Lab (RKLB): +80% Surge in 30 Days on Record Revenue and Backlog Growth

Key Takeaways

  • RKLB stock surged +80% over the past 30 days, driven by record Q1 revenue of $200.3 million (up 63.5% YoY) and a $2.2 billion backlog.
  • Quarterly performance shows +74% gain, fueled by major defense contracts and analyst upgrades.
  • Strong launch contracts, including the largest in company history for Neutron and Electron missions, boosted investor confidence.
  • Positive analyst sentiment with price targets raised to $120, amid expanding space systems revenue.
  • Key risks include Neutron development delays and high valuation multiples.

Understanding Rocket Lab (RKLB) and Its Market Position

Rocket Lab USA, Inc. (RKLB) operates as an end-to-end space company, delivering launch services and spacecraft components. The core of its business centers on the Electron rocket for small satellite launches, the forthcoming Neutron medium-lift vehicle, and space systems such as satellite manufacturing and subsystems. In the competitive aerospace and defense sector, Rocket Lab stands out as a leader in dedicated small satellite launches, with over 70 missions already manifested. From what I see, its vertically integrated model—bolstered by recent acquisitions—enables revenue diversification beyond launches into higher-margin space systems. This approach has proven resilient amid rising demand for satellite constellations and defense applications.

RKLB Stock Performance: 30-Day Run-Up vs. Quarterly Gains

In the last 30 days, RKLB stock climbed from around $73.60 to $132.55, reflecting a +80% increase. The advance was volatile yet trend-driven, highlighted by a sharp 34% surge on Q1 earnings day (May 8), followed by sustained gains tied to contract announcements.

Over the past quarter, the stock rose from about $70 in mid-February to $132.55, posting a +74% gain (accounting for some data inconsistencies around Feb 15 at ~$70). It traded range-bound initially before accelerating on key operational catalysts, outperforming the broader aerospace sector.

Key Catalysts Behind RKLB's 30-Day Rally

The main driver was Rocket Lab's Q1 2026 earnings release on May 8, which delivered record revenue of $200.3 million (up 63.5% YoY), GAAP gross margins of 38.2%, and a backlog surpassing $2.2 billion (up 20% QoQ). These results exceeded analyst expectations, with losses narrowing to $0.07 per share, sparking a 34% single-day jump.

Additional company news fueled the momentum: the largest launch contract in its history for five Neutron and three Electron missions through 2029 with an undisclosed customer, alongside 31 new contracts in Q1—surpassing all of 2025. Defense sector wins stood out, including a $190 million HASTE hypersonic deal and a $30 million agreement with Anduril, underscoring robust demand.

Analysts responded with upgrades, as Needham lifted its target to $120 (Buy), TD Cowen matched at $120, and others adjusted to $105-$98, signaling confidence in backlog conversion. I also checked this using Tickeron’s AI Screener to gauge how RKLB stacks up against industry peers. Broader positive sentiment in space stocks provided further tailwinds.

Quarterly Performance Drivers for RKLB

The quarter's +74% advance stemmed from consistent execution and growing demand. Early volatility transitioned into steady gains, propelled by defense contracts such as the $190M MACH-TB 2.0 hypersonic program and collaborations with Raytheon on Space Force interceptors.

Industry trends like increased satellite deployments and hypersonics testing played a role, with Rocket Lab's HASTE vehicle proving particularly effective. Macro support from U.S. defense spending enhanced visibility, as the backlog swelled to $2.2B, pointing to multi-year revenue potential.

Institutional buying and sector re-rating—evident among peers like SPACE—amplified the move. Improvements in launch cadence and Neutron development helped counterbalance supply chain worries.

Why I Rely on Tickeron’s Trending AI Robots

In my analysis workflow, I often turn to Tickeron’s Trending AI Robots page, which highlights top-performing AI trading bots from a library of hundreds of algorithms across thousands of tickers and markets. This section focuses on bots delivering the strongest recent returns, aligned with current trends, and backed by solid metrics like win rate, profit factor, and drawdown. Covering strategies from momentum and mean reversion to pattern recognition on intraday to long-term timeframes, these bots benefit from rigorous backtesting and real-time validation. They provide objective, data-driven insights that help cut through emotional noise. I find it valuable for spotting bots that match my trading approach and monitoring their live results.

What's Next for RKLB: Key Forecast Drivers

Looking ahead, I'm watching Q2 earnings closely for progress on backlog conversion and margin expansion. Neutron rocket milestones, including test flights, will be pivotal given potential delay risks.

Trends in satellite mega-constellations and hypersonics could spur more contracts. Broader factors like U.S. defense budgets and interest rates may shape valuations.

One thing that stands out is strategic initiatives, such as the Motiv Space Systems acquisition and key partnerships, which advance vertical integration. Analyst revisions and launch success rates will likely influence near-term sentiment. In my view, these elements will determine if the momentum holds.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Alicia's AvatarAlicia|Beginner

RKLB's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RKLB turned positive on July 31, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RKLB broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RKLB entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.280) is normal, around the industry mean (7.037). P/E Ratio (0.000) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (55.249) is also within normal values, averaging (20.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RKLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Rocket Lab (RKLB): +80% Surge in 30 Days on Record Revenue and Backlog Growth